COMMUNIQUÉS West-GlobeNewswire

Gritstone Oncology Announces the Addition of Eugene Zhukovsky, Expert in Bispecific Biotherapeutics Development, to its Scientific Advisory Board
04/04/2019
EMERYVILLE, Calif., April 04, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Aptinyx to Present at 18th Annual Needham Healthcare Conference
04/04/2019
EVANSTON, Ill., April 04, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections
04/04/2019
WALTHAM, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel antibacterials to treat serious drug-resistant infections [...]
Final Results from The Heart EXPAND Pivotal Trial Using the Organ Care System (OCS) Heart Technology Presented at the 2019 Annual Meeting of The International Society for Heart and Lung Transplantation in Orlando
04/04/2019
ANDOVER, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- TransMedics, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced the [...]
Alpha Pro Tech, Ltd. Announces the Launch of Three New Products Expanding Building Supply Market Opportunity
04/04/2019
TECHNO SB® 25 & TECHNO SB® ULTRA Synthetic Roof Underlayment REXTREME Premium Window and Door Flashing Nogales, Ariz., April 04, 2019 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading [...]
Samumed Doses First Subject in Phase 1 Trial of SM07883, a Potential Treatment for Alzheimer’s Disease
04/04/2019
DYRK1A Inhibition as a Potential Treatment for Alzheimer’s Disease Supported by Data Presented at International Conference on Alzheimer's and Parkinson's Diseases (AD/PD™ 2019) SAN DIEGO, April 04, 2019 (GLOBE NEWSWIRE [...]
Allan Oberman Appointed Chairman of Jay Pharma’s Board of Directors
04/04/2019
TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Jay Pharma Inc., a company dedicated to developing innovative, evidence-based cannabinoid medicines to address unmet patient needs in cancer care, today announced the [...]
Progressive Care Inc. Officially Moves to Newly Purchased Building
04/04/2019
MIAMI, April 04, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, announced today that it will be moving [...]
Tower One Secures Financing for 150 Towers
04/04/2019
VANCOUVER, British Columbia, April 04, 2019 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announced today it has entered into a development [...]
IntelGenx Presents at 14th International Conference on Alzheimer’s and Parkinson’s Disease
04/04/2019
SAINT LAURENT, Quebec, April 04, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced its two Montelukast poster presentations received [...]
Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina
04/04/2019
TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American focused licensed producer of medicinal cannabis and [...]
ISRACANN Biosciences: Invest in Israel’s First Cannabis Pure-Play Public Offering -- CFN Media
04/04/2019
Seattle, Washington, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Joseph J. Galligan Appointed as Senior Advisor to BioCorRx Inc.
04/04/2019
ANAHEIM, CA, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related [...]
Tonix Pharmaceuticals Plans to Expand TNX-102 SL Phase 3 Program Beyond PTSD to Include Fibromyalgia
04/04/2019
Encouraging FDA Meeting Minutes Support Phase 3 Development of TNX-102 SL 5.6 mg in Fibromyalgia NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a [...]
RTI Surgical® Applauds Blue Cross and Blue Shield of Alabama’s Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery
04/04/2019
Decision may help more patients access RTI’s SImmetry ® Sacroiliac Joint Fusion System, a minimally invasive surgical solution for sacroiliac (SI) joint dysfunction Blue Cross and Blue Shield of Alabama is the largest [...]
Theratechnologies Announces Financial Results for the First Quarter of 2019
04/04/2019
MONTREAL, April 04, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the first quarter ended February 28, 2019. First quarter 2019 financial [...]
Theratechnologies annonce ses résultats financiers pour le premier trimestre de 2019
04/04/2019
MONTRÉAL, 04 avr. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX : TH) a annoncé aujourd’hui ses résultats financiers pour le premier trimestre clos le 28 février 2019. Faits saillants [...]
Aleafia Health Appoints Lead Independent Director
04/04/2019
TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) has appointed Loreto Grimaldi as the Lead Independent Director of the Company’s [...]
Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
04/04/2019
BRACAnalysis CDx® Test Will Be Used to Identify Germline BRCA Mutations in Men with Metastatic Castrate-Resistant Prostate Cancer SALT LAKE CITY, April 04, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN [...]

Pages